Pre-Developed Assays For Cell And Gene Therapies

Analytical development sits on the critical path for cell and gene therapies, and assay timelines and consistency can shape how quickly a program moves forward. In the opening plenary session of the Gene Therapy Analytical Development EU summit 2021, Dr Behnam Ahmadian, Global Head of Process Development for the Cell & Gene Technologies Business Unit at Lonza, introduces a library of pre-developed, fast-qualify assays. The library is intended to expedite development and harmonize methods across cell and gene therapies. For teams weighing how to standardize analytics without building each assay from scratch, Ahmadian's perspective offers a concrete model to consider. Watch the presentation to see how the library is framed.